CanSino Biologics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:CJH Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
01 Apr 25Sell€13,600,685Qm29 LimitedCompany3,244,000€4.19
18 Dec 24Buy€68,535Shou-Bai ChaoIndividual18,000€3.81
27 Nov 24Buy€100,171Xuefeng YuIndividual30,000€3.34
26 Sep 24Buy€50,154Xuefeng YuIndividual20,000€2.51
09 Sep 24Buy€42,673Xuefeng YuIndividual20,000€2.13
09 Sep 24Buy€63,843Shou-Bai ChaoIndividual30,000€2.13
25 Jul 24Buy€2,144Jing WangIndividual1,000€2.14
24 Jul 24Buy€21,909Xuefeng YuIndividual10,000€2.19
24 Jul 24Buy€15,234Jing WangIndividual7,000€2.18
15 Jul 24Buy€6,676Jing WangIndividual3,000€2.23
12 Jul 24Buy€34,323Shou-Bai ChaoIndividual15,000€2.29
10 Jul 24Buy€11,086Shou-Bai ChaoIndividual5,000€2.22
09 Jul 24Buy€44,665Xuefeng YuIndividual20,000€2.23
09 Jul 24Buy€17,236Jing WangIndividual7,800€2.21

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of CJH?
Owner TypeNumber of SharesOwnership Percentage
Private Companies3,616,9381.46%
Institutions16,742,4956.78%
Individual Insiders77,550,84831.4%
General Public149,133,52060.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 39.31% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.5%
Huihua Mao
23,463,172€125.7m0%no data
7.32%
Tao Zhu
18,072,400€96.8m0%no data
7.28%
Xuefeng Yu
17,974,200€96.3m0%no data
6.94%
Dongxu Qiu
17,134,400€91.8m0%no data
1.49%
The Vanguard Group, Inc.
3,689,483€19.8m1.45%no data
1.46%
Qm29 Limited
3,616,938€19.4m-51.9%no data
1.17%
SDIC Innovation Investment Management Co., Ltd.
2,883,810€15.4m0%1.29%
0.62%
GF Fund Management Co., Ltd.
1,532,245€8.2m0%0.01%
0.62%
BlackRock, Inc.
1,521,119€8.1m9.66%no data
0.6%
Bosera Asset Management Co., Ltd.
1,490,170€8.0m0%0.03%
0.52%
China Merchants Fund Management Company Ltd.
1,291,998€6.9m0%0.04%
0.35%
Capital Research and Management Company
873,919€4.7m-0.16%no data
0.28%
China Southern Asset Management Co., Ltd.
699,034€3.7m0%no data
0.27%
Zhongqi Shao
675,000€3.6m0%no data
0.23%
HSBC Jintrust Fund Management Company Limited
572,200€3.1m0%0.08%
0.14%
Dimensional Fund Advisors LP
348,600€1.9m-1.13%no data
0.076%
China Asset Management Co. Ltd.
188,787€1.0m0%no data
0.073%
First Trust Advisors LP
179,290€960.3k-29.1%no data
0.067%
State Street Global Advisors, Inc.
164,955€883.6k-2.4%no data
0.063%
CSOP Asset Management Limited
154,406€827.1k-16%0.01%
0.058%
Wing Yu Leung
143,471€768.6k0%no data
0.055%
Charles Schwab Investment Management, Inc.
136,868€733.1k0%no data
0.05%
Nikko Asset Management Asia Limited
123,000€658.9k0%0.03%
0.042%
First State Cinda Fund Management Company Limited
103,089€552.2k0%0.01%
0.036%
Golden Trust SinoPac Fund Management Co., Ltd.
90,000€482.1k0%0.04%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/18 06:55
End of Day Share Price 2025/05/16 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CanSino Biologics Inc. is covered by 21 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bo LiBofA Global Research
Yizheng YangChina International Capital Corporation Limited
null nullChina International Capital Corporation Limited